tiprankstipranks
ECS Botanics Surges Ahead with New Deals and Growth
Company Announcements

ECS Botanics Surges Ahead with New Deals and Growth

Ecs Botanics Holdings Ltd (AU:ECS) has released an update.

Don't Miss our Black Friday Offers:

ECS Botanics Holdings Ltd (ASX: ECS) reported a robust Q1 FY25 performance with a 22% rise in revenue, reaching $5 million, driven by increased B2C sales and exports. The company secured an exclusive eight-year license with California’s Terphogz™ and expanded its asset finance facility with NAB by $3.4 million. These strategic moves, alongside leadership enhancements, position ECS for future growth in the competitive medicinal cannabis market.

For further insights into AU:ECS stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskECS Botanics Gains Shareholder Support at AGM
TipRanks Australian Auto-Generated NewsdeskECS Botanics: Organic Growth in Medicinal Cannabis
TipRanks Australian Auto-Generated NewsdeskEcs Botanics Boosts Loan Facility and Launches New Product
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App